Document is current
Any future updates will be listed below
-
Authors
Shelton, Karli
Dang, Phu
McCorkle, Courtney
Mallipaddi, Pooja
Hollman, Nicholas
Pomeroy, Jeremy
Richards, Jesse https://orcid.org/0009-0004-7985-8882
- License Information
-
More Information
Article History
Received: 4 December 2024
Accepted: 18 June 2025
First Online: 28 August 2025
Declarations
:
: This study was conducted following ethical guidelines and received approval from the Institutional Review Board (IRB) at the University of Oklahoma, ensuring compliance with all necessary ethical standards for research involving human subjects. Informed consent was obtained from all participants.
: Not applicable.
: Dr Richards reports being on speaker’s bureau for Eli Lilly, Novo Nordisk, and Rhythm pharmaceutical. Dr Richards is on advisory board for Eli Lilly and is an independent consultant for Palatin technologies. Dr. Pomeroy has received research funding from Rhythm Pharmaceuticals. The other authors declare that they have no competing interests.
